CLINICAL_TRIALS
trial_result
· 2017-03-31
Clinical Trial Update: Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating preoperative cisplatin and bevacizumab in ER-, PR-, HER2-negative breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-31